Porton Pharma Solutions Ltd. (SHE:300363)
23.79
+0.42 (1.80%)
Feb 3, 2026, 3:04 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 12.62 billion as of February 3, 2026. Its market cap has increased by 51.06% in one year.
Market Cap
12.62B
Enterprise Value
13.18B
Revenue
3.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
23.79
Market Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 12.62B, an increase of 220.37%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 12.85B | 2.37% |
| Dec 31, 2025 | 12.55B | 45.94% |
| Dec 31, 2024 | 8.60B | -37.37% |
| Dec 29, 2023 | 13.73B | -38.42% |
| Dec 30, 2022 | 22.31B | -54.20% |
| Dec 31, 2021 | 48.70B | 145.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shyndec Pharmaceutical | 14.00B |
| Zhejiang Medicine | 13.60B |
| Zhejiang Jingxin Pharmaceutical | 13.53B |
| Wedge Industrial | 13.44B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.36B |
| Guangdong Taienkang Pharmaceutical | 13.34B |
| Shenzhen Chipscreen Biosciences | 12.47B |
| Beijing Foyou Pharma CO.,LTD | 12.18B |